K. Riedel

1.8k total citations
44 papers, 1.4k citations indexed

About

K. Riedel is a scholar working on Molecular Biology, Electrical and Electronic Engineering and Bioengineering. According to data from OpenAlex, K. Riedel has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Electrical and Electronic Engineering and 10 papers in Bioengineering. Recurrent topics in K. Riedel's work include Electrochemical sensors and biosensors (11 papers), Analytical Chemistry and Sensors (10 papers) and Advanced Chemical Sensor Technologies (7 papers). K. Riedel is often cited by papers focused on Electrochemical sensors and biosensors (11 papers), Analytical Chemistry and Sensors (10 papers) and Advanced Chemical Sensor Technologies (7 papers). K. Riedel collaborates with scholars based in Germany, Sweden and Tanzania. K. Riedel's co-authors include Frieder W. Scheller, Jürgen Burhenne, Reinhard Renneberg, Walter E. Haefeli, Gerd Mikus, H Laufen, Jens Rengelshausen, T. Thomsen, Eleni Aklillu and Julia Engl and has published in prestigious journals such as Water Research, Applied Microbiology and Biotechnology and Sensors and Actuators B Chemical.

In The Last Decade

K. Riedel

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Riedel Germany 20 432 305 295 271 264 44 1.4k
Léon Reubsaet Norway 32 75 0.2× 293 1.0× 975 3.3× 90 0.3× 98 0.4× 117 3.0k
Mamdouh R. Rezk Egypt 35 240 0.6× 447 1.5× 276 0.9× 111 0.4× 524 2.0× 120 2.6k
Haitao Lü China 22 288 0.7× 122 0.4× 559 1.9× 198 0.7× 58 0.2× 57 1.6k
Rosa I. Sánchez United States 22 458 1.1× 57 0.2× 498 1.7× 133 0.5× 21 0.1× 50 1.4k
I.J. McGilveray Canada 21 107 0.2× 31 0.1× 317 1.1× 240 0.9× 45 0.2× 70 1.6k
Don Farthing United States 20 60 0.1× 97 0.3× 245 0.8× 45 0.2× 89 0.3× 37 1.3k
Shailesh Shah India 28 57 0.1× 80 0.3× 238 0.8× 91 0.3× 57 0.2× 160 2.3k
Katja Heinig Switzerland 25 35 0.1× 64 0.2× 513 1.7× 76 0.3× 130 0.5× 57 1.6k
Ahmed M. Abdel‐Megied Egypt 20 105 0.2× 175 0.6× 249 0.8× 43 0.2× 63 0.2× 46 1.0k
Chirag Patel India 23 175 0.4× 40 0.1× 534 1.8× 133 0.5× 36 0.1× 127 1.8k

Countries citing papers authored by K. Riedel

Since Specialization
Citations

This map shows the geographic impact of K. Riedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Riedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Riedel more than expected).

Fields of papers citing papers by K. Riedel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Riedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Riedel. The network helps show where K. Riedel may publish in the future.

Co-authorship network of co-authors of K. Riedel

This figure shows the co-authorship network connecting the top 25 collaborators of K. Riedel. A scholar is included among the top collaborators of K. Riedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Riedel. K. Riedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ngaimisi, Eliford, Omary Minzi, Sabina Mugusi, et al.. (2014). Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4 -hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment. Journal of Antimicrobial Chemotherapy. 69(12). 3311–3319. 24 indexed citations
2.
Egerer, Gerlinde, et al.. (2013). Steady-state pharmacokinetics and metabolism of voriconazole in patients. Journal of Antimicrobial Chemotherapy. 68(11). 2592–2599. 53 indexed citations
3.
Habtewold, Abiy, Wondwossen Amogne, Eyasu Makonnen, et al.. (2012). Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients. The Pharmacogenomics Journal. 13(6). 484–489. 41 indexed citations
4.
Habtewold, Abiy, Wondwossen Amogne, Eyasu Makonnen, et al.. (2011). Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients. Journal of Antimicrobial Chemotherapy. 66(10). 2350–2361. 52 indexed citations
5.
Ngaimisi, Eliford, Sabina Mugusi, Omary Minzi, et al.. (2011). Effect of Rifampicin and CYP2B6 Genotype on Long-Term Efavirenz Autoinduction and Plasma Exposure in HIV Patients With or Without Tuberculosis. Clinical Pharmacology & Therapeutics. 90(3). 406–413. 66 indexed citations
6.
Markert, Christoph, et al.. (2011). Determining the Time Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using A Limited Sampling Strategy. Clinical Pharmacology & Therapeutics. 90(5). 666–673. 106 indexed citations
7.
Ngaimisi, Eliford, Sabina Mugusi, Omary Minzi, et al.. (2010). Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients. Clinical Pharmacology & Therapeutics. 88(5). 676–684. 92 indexed citations
8.
Mikus, Gerd, Jens Rengelshausen, Ru Ding, et al.. (2006). Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir. Clinical Pharmacology & Therapeutics. 80(2). 126–135. 126 indexed citations
9.
Riedel, K., et al.. (2006). Determination of Three Carcinogenic Aromatic Amines in Urine of Smokers and Nonsmokers. Journal of Analytical Toxicology. 30(3). 187–195. 101 indexed citations
10.
Rengelshausen, Jens, K. Riedel, Jürgen Burhenne, et al.. (2005). Opposite effects of short-term and long-term St John’s wort intake on voriconazole pharmacokinetics. Clinical Pharmacology & Therapeutics. 78(1). 25–33. 105 indexed citations
11.
Riedel, K., et al.. (1998). Screening of xenobiotic compounds degrading microorganisms using biosensor techniques. Microbiological Research. 153(3). 239–245. 15 indexed citations
12.
Riedel, K., et al.. (1994). Enantioselective gas chromatographic assay with electron-capture detection for amlodipine in biological samples. Journal of Chromatography B Biomedical Sciences and Applications. 655(2). 225–233. 40 indexed citations
14.
Riedel, K., et al.. (1990). Amperometric determination of ammonium ions with a microbial sensor. Journal of Chemical Technology & Biotechnology. 47(2). 109–116. 7 indexed citations
15.
Riedel, K., Reinhard Renneberg, & Frieder W. Scheller. (1990). Adaptable Microbial Sensors. Analytical Letters. 23(5). 757–770. 22 indexed citations
16.
Riedel, K., Reinhard Renneberg, & Frieder W. Scheller. (1989). Studies in peptide utilization by microorganisms using biosensor techniques. Bioelectrochemistry and Bioenergetics. 22(2). 113–125. 7 indexed citations
17.
Riedel, K., et al.. (1988). Formation of some extracellular enzymes during the exponential growth ofBacillus subtilis. Folia Microbiologica. 33(2). 88–95. 13 indexed citations
18.
Riedel, K., et al.. (1988). A microbial sensor for peptides. Applied Microbiology and Biotechnology. 28(3). 6 indexed citations
19.
Riedel, K., et al.. (1987). Formation of extracellular neutral proteinase and the stringent response inBacillus subtilis. Folia Microbiologica. 32(2). 96–100. 3 indexed citations
20.
Renneberg, Reinhard, K. Riedel, & Frieder W. Scheller. (1985). Microbial sensor for aspartame. Applied Microbiology and Biotechnology. 21(3-4). 180–181. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026